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Background: Many indigenous plants of Mascarene Islands have been used in folkloric medicine to manage
diabetes but few species have received scientific attention. Selected traditional medicinal plants (Antidesma
madagascariense Lam. -Euphorbiaceae (AM), Erythroxylum macrocarpum O.E.Schulz -Erythroxylaceae (EM),
Pittosporum senacia Putterl -Pittosporaceae (PS), Faujasiopsis flexuosa Lam. C.Jeffrey -Asteraceae (FF), Momordica
charantia Linn -Cucurbitaceae (MC) and Ocimum tenuiflorum L -Lamiaceae (OT) were evaluated for their antioxidant,
antiglycation and cytotoxic potential in vitro.
Methods: Graded concentrations (1.25-100 μg/mL) of the crude methanolic and water extracts and fractions
(dichloromethane, ethyl-acetate, n-butanol and water) were evaluated for abilities to scavenge 2,2-diphenyl-2-
picrylhydrazyl hydrate (DPPH), nitric oxide (NO), superoxide (SO) radicals and to inhibit lipoxygenase and formation
of advanced glycation endproduct (AGE) in vitro. The MTT (3-(4, 5-dimethylthazol-2-yl)-2,5-diphenyl tetrazonium
bromide) cytotoxicity test was performed on 3T3 cell line.
Results: Only IC50 for DPPH, SO, NO and lipoxygenase for AM, FF and OT crude extracts and fractions were
comparable to ascorbic acid and quercetin activity. Crude aqueous extracts of AM and FF showed IC50 of 4.08 and
3.89 μg/mL respectively for lipoxygenase which was significantly lower (p < 0.05) than quercetin (10.86 ± 0.68 μg/
mL). The three crude aqueous extracts of these plants and their n-butanol fractions also showed antiglycation
activities (p < 0.05) comparable to aminoguanidine. Increasing concentrations (250-2000 μg/mL) of the six crude
extracts (Methanol and water) and their fractions did not inhibit mitochondrial respiration as measured by MTT
cytotoxicity assay.
Conclusion: AM, FF and OT crude extracts and fractions have potent antioxidant and antiglycation properties with
no apparent cytotoxicity and might have prophylactic and therapeutic potentials in the management of diabetes
and related complications. Our study tends to validate the traditional use of these medicinal herbs and food plants
as complementary and alternative medicines.Background
The local population of the Mascarene Islands has a
deep-rooted interest in the use of herbal medicine. Many
indigenous, endemic and exotic plant species have been
used in folkloric medicine to treat and manage various
ailments of man including chronic pathologies such as
diabetes mellitus (DM) and cardiovascular diseases.
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distribution, and reproduction in any mediummedicinal plant preservation and study is vital because
such plants are fully adapted to local environment and
conditions compared to exotic species [1,2]. Pharmaco-
logically active compounds and phytochemicals isolated
from endemic and indigenous plants used in folk medi-
cine have been the areas of interest [3-6]. Currently, sev-
eral kinds of preparations from various exotic, endemic
and indigenous plants are sold as decoctions or “tisanes”
in several markets to treat minor ailments and major
pathologies, including DM. DM in Mauritius is becom-
ing a devastating scourge with more than 120,000 cases
reported and 4.6% death from DM complications suchCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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has one of the highest prevalence of diabetes in the
world with nearly one in five of adults above the age of
30 years suffering from diabetes. Complications and side
effects associated with DM and failure of existing anti-
diabetic drugs are forcing researchers to come up with
long term and sustainable solutions for management of
diabetes.
Nonetheless, few antidiabetic medicinal plants of the
Mascarene Islands particularly Mauritius, have received
scientific attention and complete evidence based valid-
ation is missing. In the present study, selected endemic
and exotic medicinal plants, of the Mascarene Islands,
which are traditionally used for management of diabetes,
have been investigated for their possible antioxidant,
antiglycation and cytotoxicity properties in vitro.
Materials and methods
Plant materials
Leaves of the endemic and indigenous plants; Antidesma
madagascariense Lam. - Euphorbiaceae (AM-
FM012005), Erythroxylum macrocarpum O.E.Schulz -
Erythroxylaceae (EM- FM022005), Pittosporum senacia
Putterl - Pittosporaceae (PS- FM032005), Faujasiopsis
flexuosa (Lam) C.Jeffrey- Asteraceae (FF- FM042005),
common to the Mascarene Islands were collected from
Conservation Management Areas (Maccabé forest) situ-
ated in the upper humid region of Petrin and Forest-
Side conservation area, Mauritius. Exotic plant Ocimum
tenuiflorum L- Lamiaceae (OT- FM052005) were
obtained from the University of Mauritius farm. Fresh
Momordica charantia Linn- Cucurbitaceae (MC-
FM062005) were obtained from a commercial source
and prepared as described previously. The Curator of
the National Herbarium, at the Mauritius Sugar Industry
Research Institute confirmed the identity of the plants
and voucher specimen deposited therein. The plant
materials were prepared as reported previously [4,5].
Extract preparation
Powdered (10 g) plant materials were extracted to ex-
haustion with 50 mL of water in a Soxhlet apparatus for
5 h. The solvent was then distilled off under reduced
pressure and temperature (40°C) to afford crude plant
extract. The extracts were concentrated in vacuo using a
rotary evaporator (Model Buchi rotavapor R-114, Switz-
erland). The resultant concentrate was measured and
the gummy material collected in the appropriate solvent
for examination. Methanolic extracts were obtained by
triple soaking in 80% methanol at room temperature for
3 days and the solvent removed under reduced pressure.
The paste-like suspension was diluted in DMSO for fur-
ther experiments. Crude methanolic extracts were then
fractionated by solvent-solvent extraction procedure intodichloromethane, ethyl-acetate, n-butanol and aqueous
fractions for two successive 24-h periods respectively
[3,4,8]. In all, six different extracts and fractions per me-
dicinal plant were tested for biological activity in vitro.
DPPH (2,2-diphenyl-2-picrylhydrazyl hydrate) radical
scavenging assay
Radical scavenging activity of the different plant extracts
and respective fractions against stable DPPH (2,2-diphe-
nyl-2-picrylhydrazyl hydrate, Sigma-Aldrich) was deter-
mined spectrophotometrically [9]. Extract solutions were
prepared by dissolving 1 mg/mL of the crude extract in
1 mL of DMSO. The concentration of DPPH was main-
tained at 300 mM with variable concentrations of sam-
ple. The solution of DPPH in ethanol was prepared on a
daily basis, and prior to UV measurements. 10 μL (con-
centration ranged from 12.5 to 10 μg/mL) of each sam-
ple was dissolved in DMSO and mixed with 95 mL of
DPPH in ethanol. The mixture was dispersed in a 96-
well plate and incubated at 37°C for 30 min and the ab-
sorbance at 515 nm was measured by 96-well microtitre
plate reader (Spectramax plus 384 Molecular Device,
USA), and percentage radical scavenging activity was
determined in comparison with the DMSO-treated
(negative control). Ascorbic acid was used as a positive
control. Results were expressed as percentages compared
to control and the corresponding IC50 calculated.
Nitric oxide radical inhibition assay
The reaction mixture (100 μL) containing sodium nitro-
prusside (10 mM, 70 μL), phosphate buffer saline (1 mM,
20 μL) and extract or standard solution (0.1 mL) was incu-
bated at 25°C for 90 min in 96-well microtitre plates. The
absorbance of these solutions was measured at 570 nm
against the corresponding blank solutions using spectro-
photometer (Spectronic Genesys 8, Rochester, USA).
Results were expressed as percentages compared to nega-
tive control and the corresponding IC50 calculated [9]. As-
corbic acid was used as a positive control.
Superoxide anion radical scavenging activity
In this experiment, the superoxide radicals were gener-
ated in 200 μL of phosphate buffer (0.1 M, pH 7.5) con-
taining 40 μL of NBT (80 mM) solution, 40 μL NADH
(280 mM) solution and sample solution of graded con-
centrations (6.25-1000 μg/mL) in water. 10 μL of test
samples were dissolved in DMSO and the reaction was
started by adding 20 μL of phenazine methosulphate so-
lution (8 mM) to the mixture. The reaction mixture was
incubated at 25oC for 5 min and the absorbance at 560
nm was measured against the blank at 23oC [10] in 96-
well microtitre plate reader. Ascorbic acid was used as a
positive control and DMSO as negative control. Results
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the corresponding IC50 calculated.Non-enzymatic antiglycation activities
Albumin-derived advanced glycation endproducts
(AGEs) were measured using fluorometry as described
previously [11,12]. Briefly, 1mg/ml of fatty acid-free bo-
vine serum albumin (BSA) was incubated with D-
glucose (200-400 mM) ± 100 μl of herb or spice
extracts in 0.2 M potassium phosphate buffered saline
(pH 7.4 containing 0.01% sodium azide) at 37°C for
defined time periods. Aliquots of the reaction mixture
were removed at weekly intervals and fluorescent AGEs
were assessed by their emission at 440 nm following ex-
citation at 370nm using a spectrofluorimeter (F-7000
FL) [11]. The reaction was stopped by adding 10 μl of
100% (w/v) tricholoroacetic acid and after ten minutes
the mixtures were centrifuged at 10000 g. The precipi-
tate was re-dissolved in alkaline phosphate buffered sa-
line (PBS) and quantified for the relative amount of
fluorescent AGEs. Complete inhibition of fluorescent
AGEs was assumed to occur when fluorescence was
inhibited to that of albumin in the absence of glucose;
which was used as a negative control. Any sample
giving fluorescence equal to the fluorescence of BSA/
glucose implied that there was no inhibition of glyca-
tion; whereas, any sample giving fluorescence lower
than that of BSA/glucose indicated that there was inhib-
ition of glycation by the extract present. Aminoguani-
dine was included as a positive control. The percentage
inhibition of glycation of each of the negative control
and plant extract was calculated as follows: [(Fluores-
cence of specimen – fluorescence of BSA/Glucose)/
Fluorescence of BSA/Glucose] X 100. Results were
expressed as percentages compared to negative control
and the corresponding IC50 calculated.Assay for inhibition of 15-lipoxygenase
Inhibition of 15-lipoxygenase was carried out using soy-
bean lipoxygenase type 1-B (Sigma, St. Louis, MO, USA
and/or Fluka, Buchs, Switzerland) as described by Lyck-
ander & Malterud, [13]. Measurements of increase in ab-
sorbance at 234 nm for 30-90 sec after enzyme addition
were done in 0.2 M borate buffer (pH 7.5) with linoleic
acid (134 μM) as substrate and an enzyme concentration
of 167 U/mL, using test substance solutions in DMSO
or water or (for blanks) DMSO or water alone. Enzyme
inhibitory activities were calculated from the values for
absorption increase per time unit, as supplied from the
software of the spectrometer. Three or more parallels
for blanks and for samples were measured [13,14].
Results were expressed as percentages compared to
negative control and the corresponding IC50 calculated.MTT (3-(4, 5-dimethylthazol-2-yl)-2, 5-diphenyl
tetrazonium bromide) cytotoxicity assay
In the present investigation, 3T3 cell line clone A31 adher-
ent cell line was used and cytotoxicity on these cells was
assessed as described previously [15,16]. For each experi-
ment, cultures were seeded from frozen stocks. 3T3 cells
were maintained in Ham’s F12 medium supplemented
with 10% fetal calf serum (FBS) and 1% antibiotic solution.
All cell lines were incubated at 37°C in a 5% CO2 atmos-
phere and were in the logarithmic phase of growth at the
time of the neutral red (NR) and tetrazolium (MTT)
assays. Cells were harvested and seeded into 96-well tissue
culture plates at a density of 1x104 cells per well of ali-
quots of medium (200 μl). The cells were allowed to ad-
here to the wells for 24 h at 37°C in a humidified
atmosphere optimized with 5% CO2 in air. The next day,
the plant extract/fractions were added at the desired final
concentrations and incubated for 72h. All experiments
were performed at least four times. Phosphate-buffered sa-
line (PBS) was used as a negative. After the 72 h exposure
period, the toxic endpoints were determined at 570 and
620 nm. Viability was defined as the ratio (expressed as a
percentage) of absorbance of treated cells to untreated
cells that served as negative control.
Statistical analysis
All data were expressed as means ± SD for three experi-
ments. The difference between the means ± SD of the
antioxidant and antiglycation activity between the con-
trol (without plant extract) and experimental group were
assessed using the one way ANOVA test. P values < 0.05
were considered statistically significant. Statistical ana-
lyses were performed using Excel software (Microsoft
2007) and SPSS version 16.0 for Windows 2007 [5,6].
Results
Antioxidant activities
Antioxidant properties of the crude extracts and differ-
ent fractions of the six plants were evaluated for their
abilities to scavenge 2,2-diphenyl-2-picrylhydrazyl hy-
drate (DPPH), nitric oxide (NO) and superoxide anion
(SO) radicals in vitro. The results obtained are summar-
ized in Tables 1,2,3. Graded concentrations of the differ-
ent extracts and fractions tested ranged from 12.5-100
μg/mL and the results expressed as percentage radical
scavenging activities. As shown in Tables 1,2,3 only
crude methanol and water extracts and corresponding
fractions of AM, FF and OT were found to posses sig-
nificant radical scavenging abilities (though moderate)
compared to the control (without extract added).
The percentage DPPH radical scavenging activities of
AM, FF and OT ranged between 20.13 ± 3.46 to 93.68 ±
8.69, 29.46 ± 3.87 to 97.08 ± 11.23, and 24.19 ± 1.08 to
94.86 ± 8.09 respectively. For AM, the crude water and




Crude water extract Crude methanol extract Dichloromethane Ethylacetate n-butanol Water fraction
100 9.23 ± 2.29 8.63 ± 1.03 4.26 ± 0.69 13.26 ± 0.96 14.59 ± 1.09 11.23 ± 1.01
(20.13 ± 3.46*) (23.39 ± 1.36) (87.52 ± 6.59*) (92.86 ± 7.16*) (93.68 ± 8.69*) (80.13 ± 7.54*)
{67.46 ± 9.56*} {75.56 ± 7.65*} {78.67 ± 6.15*} {93.45 ± 9.14*} {97.08 ± 11.23*} {72.78 ± 5.36*}














j9.86 ± 1.23j j12.03 ± 1.06j j18.16 ± 2.13j j15.69 ± 1.39j j15.46 ± 0.23j j7.39 ± 1.09j
50 4.21 ± 1.23 3.98 ± 1.11 2.04 ± 0.23 7.49 ± 0.96 9.18 ± 0.23 5.13 ± 1.03
(14.36 ± 0.89) (12.39 ± 0.69) (61.43 ± 5.67*) (75.67 ± 4.56*) (75.64 ± 3.68*) (62.14 ± 5.67*)
{52.16 ± 7.65*} {58.89 ± 5.94*} {63.19 ± 7.62*} {72.14 ± 8.56*} {76.37 ± 9.56*} {55.09 ± 5.53*}














j4.61 ± 0.96j j7.01 ± 0.69j j10.69 ± 1.29j j8. 69 ± 0.36j j8.63 ± 0.19j j3.59 ± 0.67j
25 2.15 ± 0.60 1.23 ± 0.22 1.09 ± 0.09 5.29 ± 0.63 5.69 ± 0.11 2.39 ± 0.36
(9.19 ± 1.13) (8.46 ± 1.03) (46.49 ± 1.98*) (53.36 ± 3.79*) (62.14 ± 1.69*) (50.23 ± 2.97*)
{40.14 ± 6.15*} {42.15 ± 6.54*} {40.18 ± 6.81*} {57.09 ± 6.36*} {54.76 ± 3.39*} {48.13 ± 4.46*}














j2.19 ± 0.13j j3.69 ± 0.23j j5.18 ± 0.96j j5.19 ± 0.08j j3.14 ± 0.08j j1.56 ± 0.16j
12.5 1.26 ± 0.35 0.68 ± 0.13 0.97 ± 0.11 2.09 ± 0.16 2.57 ± 0.09 0.98 ± 0.15
(4.16 ± 0.56) 5.34 ± 0.87 (30.69 ± 1.63*) (38.56 ± 2.67*) (41.64 ± 1.59*) (28.26 ± 2.39*)
{29.46 ± 3.87}* {34.19 ± 5.87*} {32.49 ± 4.57*} {40.18 ± 5.42*} {36.15 ± 2.23*} {29.86 ± 5.21*}














j1.01 ± 0.01j j1.69 ± 0.02j j2.09 ± 0.39j j1.69 ± 0.01j j0.69 ± 0.01j j1.06 ± 0.01j
Note. Values are means ± SD of three independent experiments. EM (AM) {FF} [OT]
R
PS
R jMCj. *Values significantly different (p < 0.05) from the control in each group.
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OT whereby all the extracts and fractions were active.
The percentage SO radical scavenging of AM, FF and
OT ranged between 17.19 ± 0.67 to 99.53 ± 7.53, 15.14 ±
2.67 to 86.59 ± 10.18, and 14.29 ± 3.97 to 80.69 ± 10.69
respectively. For both AM and OT, the highest scaveng-
ing activities were observed for the ethylacetate fraction
99.53 ± 7.53 and 80.69 ± 10.69 respectively. A fair acti-
vity was observed for PS and MC ethylacetate fractions
(15.69 ± 1.69 and 32.93 ± 2.67 respectively).
The percentage NO radical scavenging of AM, FF and
OT ranged between 65.56 ± 7.56 to 19.29 ± 1.39, 17.19 ±
1.64 to 72.39 ± 3.36, and 19.17 ± 1.08 to 55.24 ± 3.34
respectively. The highest activities for AM, FF and OT
were recorded for n-Butanol (65.56 ± 7.56), ethylacetate
(72.39 ± 3.36) and water fraction (55.24 ± 3.34) respectively.
The DPPH IC50 values for AM, FF and OT (Figure 1)
ranged from 3.94 to 87.05 μg/ mL, 3.39 to 4.87 μg/mL, and
4.00 to 6.67 μg/mL respectively. The SO IC50 values for
AM, FF and OT (Figure 2) ranged from 3.81 to 13.26 μg/
mL, 4.95 to 37.01 μg/mL, and 5.05 to 39.48 μg/mL. TheNO IC50 values for AM, FF and OT (Figure 3) ranged from
6.29 to 25.24 μg/mL, 6.06 to 10.30 μg/mL, and 8.83 to
13.95 μg/mL. All extracts and fractions showed DPPH IC50
values more or less similar to the positive control ascorbic
acid 4.16 μg/mL except the crude water and methanol
extracts (87.05 and 70.09 μg/mL respectively).The ethylace-
tate fractions of AM and FF showed best activities (3.94 μg/
mL and 3.39 respectively), whereas the n-butanol fraction
of OT was the most potent extract showing an IC50 of 4.00
μg/mL. Only the dichloromethane fraction for AM, FF and
OT; and crude water extracts of FF and OT; and crude
methanol and water fraction of OT showed SO IC50 values
higher (p < 0.05) than the positive control ascorbic acid
(4.30 μg/mL). The best SO IC50 value for AM was the ethy-
lacetate fraction (3.81 μg/mL), for FF crude methanol/water
extract (4.95 μg/mL) and OTan IC50 of 5.05 μg/mL.
Antiglycation activities
The concentrations of extracts and fractions tested for
antiglycation activities ranged from 250 to 2000 μg/mL
(Table 4). Results showed that AM, FF, OT and MC




Crude water extract Crude methanol extract Dichloromethane Ethylacetate n-butanol Water fraction
100 5.23 ± 1.23 2.23 ± 0.69 10.89 ± 1.46 19.36 ± 2.30* 12.69 ± 1.34 2.39 ± 0.36
(82.39 ± 7.34*) (98.97 ± 5.37*) (47.77 ± 6.34*) (99.53 ± 7.53*) (98.67 ± 5.04*) (68.07 ± 4.31*)
{65.68 ± 9.67*} {74.23 ± 7.68*} {22.69 ± 1.09*} {55.44 ± 2.39*} {82.80 ± 12.69*} {86.59 ± 10.18*}














j7.29 ± 1.06j j5.09 ± 1.00j j12.29 ± 1.27j j32.93 ± 2.67*j j10.24 ± 2.13j j8.23 ± 0.96j
2.56 ± 0.99 1.26 ± 0.11 7.79 ± 1.47 9.67 ± 1.67 6.35 ± 0.69 1.09 ± 0.37
50 (58.64 ± 3.15*) (70.64 ± 5.43*) (23.67 ± 1.08*) (74.59 ± 6.07*) (72.19 ± 3.32*) (52.39 ± 2.01*)
{40.29 ± 6.54*} {57.19 ± 6.45*} {11.09 ± 0.98} {30.27 ± 2.79*} {52.69 ± 9.67*} {50.19 ± 5.67*}














j3.19 ± 1.01j j2.39 ± 0.16j j9.25 ± 0.67j j18.39 ± 1.97j j7.24 ± 1.01j j6.58 ± 0.64j
0.56 ± 0.01 0.59 ± 0.01 4.69 ± 1.06 5.49 ± 1.39 4.56 ± 0.34 0.67 ± 0.09
25 (41.19 ± 2.04*) (56.38 ± 2.38*) (11.29 ± 0.67) (59.78 ± 3.08*) (54.39 ± 1.17*) (35.56 ± 1.86*)
{18.09 ± 2.31*} {41.09 ± 3.47*} {6.57 ± 0.73} {14.67 ± 1.98} {36.48 ± 5.24*} {28.49 ± 1.38*}














j1.29 ± 1.00j j1.18 ± 0.23j j6.58 ± 2.39j j10.67 ± 2.01j j4.12 ± 0.96j j3.28 ± 0.28j
0.06 ± 0.01 0.13 ± 0.01 2.65 ± 0.67 2.67 ± 0.69 1.67 ± 0.09 0.01± 0.01
12.5 (28.98 ± 1.31*) (42.46 ± 2.28*) (7.69 ± 0.17) (42.19 ± 1.38*) 36.49 ± 0.37* (17.19 ± 0.67*)
{10.39 ± 0.96} {17.19 ± 1.96*} {2.39 ± 0.24} {7.09 ± 0.97} {15.36 ± 1.74*} {15.14 ± 2.67*}














j0.59 ± 0.01j j0.69 ± 0.01j j2.18 ± 0.29j j5.97 ± 1.91j j1.69 ± 0.86j j1.28 ± 0.11j
Note. Values are means ± SD of three independent experiments. EM (AM) {FF} [OT]
R
PS
R jMCj. *Values significantly different (p < 0.05) from the control in each
group.
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trol experiment (without the extracts added) and com-
parable to the anti-glycation drug aminoguanidine. From
the results obtained, it was observed that the degree of
antiglycation activities varies considerably from plant to
plant and also on the different fractions tested. The
ethylacetate fraction of AM showed the highest percent-
age activity (96.63 ± 10.36) and the least active fraction
was the water fraction (62.31 ± 7.65) at 2000 μg/mL. All
the tested extracts and fractions showed significant ac-
tivities (P < 0.05) except the water fraction of AM which
showed poor activity. The IC50 values for the active
fractions are summarized in Figure 4. As can been seen,
the IC50 values ranged from 16.29 ± 1.32 to 54.35 ±
2.12, 25.31 ± 1.98 to 69.54 ± 2.32, and 21.01 ± 2.06 to
68.29 ± 1.68 μg/mL for AM, FF and OT respectively.
However, only a few extracts and fractions exhibited in-
hibitory activities similar to the drug aminoguanidine.
The ethylacetate, crude methanol and n-butanol frac-
tions of AM were the most active fractions.Nonetheless, the most potent fraction appears to be n-
butanol fractions for all the three plants evaluated.
Lipoxygenase activity
The ability of the six plants crude extracts and their
fractions to inhibit the enzyme lipoxygenase is summar-
ized in Table 5. The concentrations of the extracts tested
ranged from 1.25 to 10 μg/mL. The extracts and frac-
tions showed widely varying activity. Again, AM, FF and
OT were the most active plants, with FF being the most
potent plant. However, MC seemed to exhibit a moder-
ate anti-lipoxygenase activity at higher concentration
only (10 μg/mL).
The percentage inhibition of AM ranged from 28.03 ±
0.45 to 82.46 ± 10.09, and the best activity was observed
for the crude water extract 82.46 ± 10.09 and the least
active fraction which gave significant inhibition was
the n-butanol fraction. For FF, the percentage enzyme
inhibition ranged from 26.67 ± 1.37 to 98.32 ± 7.64, and
the best activity was noted for crude methanol extract
Table 3 Nitric oxide radical scavenging activity of crude extracts and fractions of 6 plants from the Mascarene Islands
Concentrations
(μg/mL)
Nitric oxide scavenging activity
Crude water extract Crude methanol extract Dichloromethane Ethylacetate n-butanol Water fraction
100 1.23 ± 0.12 5.36 ± 0.94 3.46 ± 0.11 0.96 ± 0.09 7.68 ± 1.01 10.67 ± 1.37
(59.39 ± 2.39*) (62.73 ± 4.67*) (33.26 ± 2.54*) (65.02 ± 6.49*) (65.56 ± 7.56*) (45.21 ± 2.98*)
{59.63 ± 3.06*} {61.46 ± 2.39*} {54.97 ± 3.01*} {72.39 ± 3.36 *} {56.51 ± 4.08*} {56.04 ± 2.86*}














j3.64 ± 0.18*j j5.69 ± 0.54j j31.34 ± 2.07*j j22.36 ± 1.01*j j28.69 ± 0.68*j j5.78 ± 0.67j
0.56 ± 0.03 2.69 ± 0.64 1.69 ± 0.05 0.23 ± 0.07 6.49 ± 0.96 7.39 ± 0.96
50 (38.64 ± 1.69*) (41.31 ± 3.29*) (15.36 ± 1.06) (43.69 ± 5.46) (41.29 ± 3.69*) (21.68 ± 1.07*)
{32.46 ± 3.67*} {40.16 ± 1.07*} {27.68 ± 1.07*} {42.09 ± 2.67*} {31.10 ± 1.37*} {29.76 ± 2.01*}














j1.09 ± 0.0j j2.36 ± 0.34j j28.37 ± 1.37j j9.37 ± 0.96j j26.34 ± 1.01j j3.67 ± 0.97j
25 0.18 ± 0.02 0.96 ± 0.01 0.97 ± 0.03 0.19 ± 0.01 2.69 ± 0.31 4.19 ± 0.43
(22.67 ± 3.67*) (28.46 ± 2.87) (7.09 ± 0.96) (26.59 ± 1.09*) (29.64 ± 2.98*) (11.37 ± 0.87)
{17.19 ± 1.64*} {22.06 ± 1.11*} {12.08 ± 0.67} {28.19 ± 1.37*} {9.65 ± 0.79} {10.09 ± 1.04}














j0.19 ± 0.01j j1.94 ± 0.19j j9.37 ± 1.07j j6.54 ± 0.67j j11.97 ± 0.67j j1.67 ± 0.61j
12.5 0.09 ± 0.01 0.23 ± 0.01 0.15 ± 0.01 0.06 ± 0.01 0.37 ± 0.01 2.64 ± 0.19
(12.19 ± 1.15) (19.29 ± 1.39*) (1.23 ± 0.13) (10.69 ± 0.69) (18.67 ± 1.08*) (5.36 ± 0.36)
{9.86 ± 0.97} {10.36 ± 0.67} {4.89 ± 0.55} {12.67 ± 0.68} {2.98 ± 0.32} {6.17 ± 0.63}














j0.00 ± 0.00j j0.37 ± 0.09j j2.39 ± 0.23j j 3.67 ± 0.54j j 6.37 ± 0.37j j0.98 ± 0.09j
Note. Values are means ± SD of three independent experiments. EM (AM) {FF} [OT]
R
PS
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Figure 1 IC50 for DPPH radical scavenging properties of AM, FF
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Figure 2 IC50 for SO radical scavenging properties of AM, FF
and OT crude extracts and fractions.
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Figure 3 IC50 for NO radical scavenging properties of AM, FF
and OT crude extracts and fractions.




Crude water extract Crude methanol extract Dichloromethane Ethylacetate n-butanol Water fraction
2000 75.63 ± 7.89* 86.35 ± 5.65* 78.69 ± 6.54* 96.63 ± 10.36* 84.65 ± 6.35* 62.31 ± 7.65*
{62.31 ± 6.35*} {56.31 ± 7.09*} {68.67 ± 5.32*} {76.34 ± 5.32*} {80.36 ± 9.25*} {55.37 ± 1.32*}
[78.63 ± 6.54*] [80.56 ± 8.62*] [82.63 ± 9.32*] [56.34 ± 2.36*] [71.23 ± 7.21*] [56.31 ± 3.54*]














j6.32 ± 0.21j j7.62 ± 1.21j j6.36 ± 0.02j j5.63 ± 0.21j j6.32 ± 0.02j j1.36 ± 0.06j
1000 61.34± 5.63* 72.36 ± 5.63* 56.34 ± 5.65* 78.64 ± 6.98* 70.32 ± 2.36* 41.12 ± 3.65*
{40.65 ± 5.32*} {34.67 ± 3.21*} {42.36 ± 3.21*} {59.37 ± 4.31*} {64.65 ± 7.69*} {33.14 ± 1.65*}
[56.36 ± 7.61*] [67.66 ± 7.24*] [72.38 ± 5.62*] [38.62 ± 1.21*] [52.36 ± 3.32*] [36.52 ± 2.87*]














j5.12 ± 0.21j j2.32 ± 0.64j j5.63 ± 0.03j j3.32 ± 0.21j j5.21 ± 0.63j j2.31 ± 0.21j
500 42.62 ± 2.65* 56.64 ± 8.98* 28.36 ± 6.68* 59.61 ± 7.65* 54.61 ± 6.36* 30.14 ± 3.65*
{22.34 ± 5.65*} {12.36 ± 0.98*} {26.34 ± 8.63*} {39.87 ± 2.32*} {52.31 ± 5.32*} {19.69 ± 2.32*}
[32.16 ± 3.21*] [52.34 ± 2.36*] [52.31 ± 3.61*] [11.23 ± 0.04] [46.35 ± 5.21*] [28.61 ± 3.54*]

















j7.36 ± 1.65j j1.23 ± 0.41j j4.24 ± 0.54j j1.11 ± 0.03j j2.35 ± 0.02j j0.21 ± 0.01j
250 29.65 ± 2.32* 39.65 ± 5.65* 14.23 ± 2.65* 42.31 ± 6.35* 35.64 ± 4.09* 13.29 ± 3.65
{10.36 ± 2.35} {6.13 ± 1.35} {12.67 ± 0.36} {13.64 ± 1.21} {16.34 ± 2.31*} {8.98 ± 1.25}
[28.96 ± 1.68*] [39.78 ± 1.91*] [34.13 ± 2.31*] [9.63 ± 0.11] [32.97 ± 1.63*] [11.23 ± 0.57]














j0.23 ± 0.17j j0.36 ± 0.09j j2.98 ± 0.06j j0.68 ± 0.05j j0.69 ± 0.03j j0.00 ± 0.00j
Note. Values are means ± SD of three independent experiments. AM {FF}[OT] (MC)
R
EM
R jPSj. *Values significantly different (p < 0.05) from the control (without




























Figure 4 IC50 for antiglycation properties of AM, FF and OT
crude extracts and fractions.
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Crude water extract Crude methanol extract Dichloromethane Ethylacetate n-butanol Water fraction
10 82.46 ± 10.09* 79.75 ± 10.07* 77.88 ± 6.37* 53.71 ± 4.17* 27.46 ± 1.77* 32.80 ± 1.31*
{97.06 ± 11.67*} {98.32 ± 7.64*} {81.21 ± 5.24*} {63.94 ± 3.13*} {74.98 ± 2.23*} {67.81 ± 4.47*}
[53.69 ± 2.36*] [38.88 ± 1.09*] [52.54 ± 0.95*] [53.31 ± 1.26*] [17.87 ± 1.01*] [48.64 ± 2.07*]














j1.23 ± 0.02 j j5.62 ± 0.68j j0.96 ± 0.02j j2.36 ± 0.02j j14.96 ± 0.66*j j2.85 ± 0.51j
5 69.37 ± 9.37* 62.69 ± 6.11* 58.37 ± 3.64* 28.67 ± 3.09* 11.09 ± 0.67 19.67 ± 0.99
{70.16 ± 5.55* } {83.67 ± 4.36*} {68.69 ± 2.01*} {42.67 ± 3.15*} {56.04 ± 2.16*} {46.39 ± 3.37*}
[37.11 ± 1.39*] [18.39 ± 2.67*] [29.67 ± 0.36*] [36.56 ± 0.76*] [9.36 ± 0.67] [32.05 ± 1.16*]














j0.96 ± 0.03j j2.37 ± 0.11j j0.57 ± 0.01j j1.09 ± 0.03j j 7.09 ± 0.35j j1.06 ± 0.02j
2.5 56.09 ± 7.67* 50.37 ± 3.07* 32.67 ± 1.06* 20.37 ± 2.01* 7.19 ± 0.65 9.37 ± 0.67
{53.37 ± 4.31*} {62.37 ± 3.16*} {50.37 ± 2.67*} {37.65 ± 1.11*} {39.67 ± 1.97*} {35.67 ± 2.01*}
[26.09 ± 1.03*] [10.09 ± 1.37] [13.06 ± 0.26] [27.39 ± 1.03*] [5.36 ± 0.58] [24.31 ± 1.09*]














j0.67 ± 0.02j j1.06 ± 0.02j j0.36 ± 0.02j j0.67 ± 0.02j j4.53 ± 0.54j j0.97 ± 0.06j
1.25 32.37 ± 2.07* 29.67 ± 2.01* 28.03 ± 0.45* 11.09 ± 0.37 2.37 ± 0.53 4.09 ± 0.36
{42.37 ± 2.01*} {48.69 ± 2.16*} {32.69 ± 1.97*} {13.39 ± 0.12} {26.67 ± 1.37*} {29.67 ± 1.36*}
[10.09 ± 0.96] [6.37 ± 0.65] [7.63 ± 0.11] [11.03 ± 0.15] [3.34 ± 0.27] [9.03 ± 0.37]














j0.29 ± 0.01j j0.64 ± 0.01j j0.24 ± 0.01j j0.47 ± 0.01j j2.07 ± 0.16j j0.17 ± 0.01j
Note. Values are means ± SD of three independent experiments. AM {FF}[OT] (MC)
R
EM
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Figure 5 IC50 for lipoxygenase activity of AM, FF and OT crude
extracts and fractions.
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ition of OT for the enzyme ranged from 24.31 ± 1.09 to
53.69 ± 2.36. The best activity was obtained for the
crude water extract (53.69 ± 2.36) and the least active
fraction which gave significant inhibition was n-butanol
(24.31 ± 1.09). All extracts and fractions of MC fruits
did not inhibit lipoxygenase activity significantly (p <
0.05) except the crude methanol, dichloromethane and
the ethylacetate fractions which gave a percentage inhib-
ition of 23.03 ± 0.95, 41.13 ± 1.68 and 30.96 ± 1.33 re-
spectively. However, at lower concentrations 1.25-2.5
μg/mL, the inhibition was not significantly significant (p
> 0.05) compared to the control and hence the IC50
value was not calculated.
Figure 5 shows the IC50 values for lipoxygenase activ-
ity against the tested extracts of the three potent plants
(AM, FF and OT). The IC50 values for AM, FF and OT
ranged from 4.08 to 27.32, 3.89 to 6.13, and 8.70 to
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Figure 7 Effects of Faujasiopsis flexuosa on percentage cell
viability in vitro.
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3.89 μg/mL respectively, whereas the ethyl acetate frac-
tion of OT was the most active fraction, showing an
IC50 value of 8.70 μg/mL. The IC50 value for quercetin,
used as the positive control was 10.86 ± 0.68 μg/mL.
MTT cytotoxicity test
Increasing concentrations (250-2000 μg/mL) of AM, FF,
EM, PS, OT and MC crude extracts and fractions were
found not to significantly (p >0.05) inhibit mitochondrial
respiration as measured by the MTT assay. The results
are presented in Figures 6,7,8,9,10,11.
Discussion
Enhanced oxidative stress and the changes in antioxi-
dant capacity, which are observed in both clinical and
experimental DM, are thought to contribute to the eti-
ology of chronic diabetic complications [17]. Indeed, an
imbalance between formation of reactive oxygen species
(ROS) and antioxidants in vivo has been suggested to
play a major role in multiple chronic diseases including
diabetes. ROS, which include free radicals such as super-
oxide anion radicals, hydroxyl radicals and non free-
radical species such as H2O2 and singlet oxygen, are
various forms of activated oxygen. These molecules are
exacerbating factors in cellular injury, inflammation, car-
diovascular diseases, diabetes and aging process [18].
There have been a growing number of investigations on
the potential of antidiabetic medicinal plants as possible
antioxidants to prevent or delay chronic diabetic compli-
cations. It is generally assumed that frequent consump-
tion of plant derived phytochemicals from vegetables,
fruit, tea and medicinal herbs may contribute to the shift
in balance toward an adequate antioxidant status.
In the present study, six medicinal plants traditionally
used against diabetes were evaluated for their antioxi-
dant properties using standard bioassays such as DPPH,
NO and SO radical scavenging potentials. Findings from
the present investigation showed that AM, OT and FF
were the most active plants for all the three assays as
depicted by their low IC50 values. However, the degree
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Figure 6 Effects of Antidesma madagascariense on percentage
cell viability in vitro.and fractions gave IC50 values higher than ascorbic
acid, which is a known standard potent antioxidant.
Additionally, a clear cut trend in activity for the fractions
used was not observed. Nevertheless, the ethylacetate
fraction for the three plants tested has been shown to be
the most potent extracts. Several reports tend to show
that numerous plant derived natural products are effect-
ive antioxidants, and many medicinal plants with a long
history of use in folk medicine in different countries
against a variety of diseases have turned out to be rich
sources of antioxidants [19,20]. The advantage of natural
antioxidants is their safety and that large oral doses are
well tolerated [21]. Many antioxidant compounds, natur-
ally occurring in plant sources have been identified as
free radical or active oxygen scavengers. Recently, inter-
est has considerably increased in finding naturally occur-
ring antioxidant for use in foods or medicinal materials
to replace synthetic antioxidants, which are being
restricted due to their side effects such as carcinogenesis.
Natural antioxidants can protect the human body from
free radicals and retard the progress of many chronic
diseases as well as lipid oxidative rancidity in foods.
Hence, studies on natural antioxidants have gained in-
creasingly greater importance [18]. In the investigations
reported here, scavenging of the DPPH, SO anion and
NO radicals which are commonly used procedures and
validated against several other assays for antioxidant ac-
tivity, including some with relevance for in vivo effects
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Figure 8 Effects of Erythroxylum macrocarpum on percentage
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Figure 9 Effects of PS on percentage cell viability in vitro.
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inhibition of 15-lipoxygenase-mediated peroxidation of
linoleic acid was used. It is to be noted that, that AM,
FF and OT showed scavenging properties for all these
in vitro assay methods. Lipoxygenase is the enzyme that
peroxidizes polyunsaturated fatty acids such as linoleic
acid or arachidonic acid to their respective hydro-peroxy
derivatives. The six medicinal plants were tested for ac-
tivity against this enzyme and it was found that AM, FF
and OT were the most active fractions, showing good
correlation with their antioxidant properties as noted
against DDPH, SO and NO. The lipoxygenases have
been implicated in a number of pathological states, and
15-lipoxygenase has been suggested to play a role in the
development of atherosclerosis and diabetes, probably
due to its ability to peroxidize low-density lipoprotein
[23,24]. Investigators tend to suggest that an elevated
level of lipid peroxides in the plasma of diabetic rats and
lipid peroxidation is one of the characteristic features of
chronic diabetes. Lipid peroxidation is a free radical
induced process leading to oxidative deterioration of
polyunsaturated fatty acids and this can be prevented by
antioxidants. Additionally, inhibition of soybean 15-
lipoxygenase is generally regarded as predictive for
inhibition of the mammalian enzyme [25,26]. To this ef-
fect, it can be suggested that AM, FF and OT had pro-
found antioxidant properties as supported by the assays
carried out in this experiment. However, the phytochem-
ical constituents present in the active extracts and frac-
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Figure 10 Effects of Ocimum tenuiflorum on percentage cell
viability in vitro.need to be further investigated. Interestingly, we have re-
cently found the presence of at least tannins, flavonoids
and alkaloids in these plants which are known to possess
potent antioxidant activity. Hence, the observed antioxi-
dant activity might be due to the presence of any of
these constituents or due to a synergistic effect.
A panoply of studies have focused on the factors
involved in the pathogenesis of diabetic complications
and most seeking effective therapies [27,28]. However,
the exact cellular or molecular basis of these complica-
tions has not yet been fully elucidated [29]. Hypergly-
cemia is still considered the principal cause of diabetic
complications. Its deleterious effects are attributable,
among other things, to the formation of sugar-derived
substances called advanced glycation end products
(AGEs). AGEs are heterogeneous group of molecules
formed from the non-enzymatic reaction of reducing
sugars with free amino groups of proteins, lipids, and
nucleic acids and their formation is markedly accelerated
in diabetes because of the increased availability of glu-
cose [27]. In this study, a simple screening method to
measure the inhibitory effects of these extracts and frac-
tions and aminoguanidine on formation of fluorescent
AGEs in vitro is described. Our system used high con-
centrations of glucose to speed up the glycation reaction,
thus allowing us to undertake the evaluation in an ap-
propriate time-scale as glycation occurs very slowly
under physiological conditions [30].
In the present investigation, AM, OT and FF were
found to inhibit the formation of AGE in vitro. It is sug-
gested that the abilities to inhibit the formation of gly-
cated end products is closely related to the abilities of
the antioxidant properties of the plant extracts to scav-
enge radicals formed during the Maillard reaction which
forms the basis of glycation. Interestingly, in the current
work, extracts that were found to possess antioxidant
properties against lipoxygenase activity were also found
to possess antiglycation potential. Furthermore, a few of
the extracts were observed to possess antiglycation activ-
ities similar to the standard drug aminoguanidine, also
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Figure 11 Effects of Momordica charantia on percentage cell
viability in vitro.
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nidine prevented AGE formation by blocking carbonyl
groups on Amadori products although it is now known
to react with carbonyl groups from reducing sugars [31].
Aminoguanidine, guar gum and acarbose may act as an
antioxidant, especially at high concentrations [32]. To
this effect, it can be suggested that the antioxidant prop-
erties of the AM, FF and OT might to some extent jus-
tify the observed antiglycation properties similar to
aminoguanidine mode of action.
The MTT assay is a test of metabolic competence
based upon assessment of mitochondrial performance
relying on the conversion of yellow MTT to the purple
formazan derivative by mitochondrial succinate de-
hydrogenase in viable cells [16]. Increasing concentra-
tions of the six extracts and fractions did not affect
mitochondrial respiration as measured by the MTT cyto-
toxicity assay. Overall, the results of this assay measuring
cell integrity showed that these medicinal plants which
are widely consumed and used in traditional medicine is
not toxic over this concentration range tested.
In this study the crude aqueous extracts were used
as per the local tradition of the herbalists. The basis
for performing extractions with different solvents was
to corroborate and validate the inhibitory activity in
the aqueous extractions performed in the traditional
manner as well as to search for newer, more potent
inhibitory compounds in the organic solvents. To this
effect, it was important to assess the antioxidant
activities of the crude water extracts in order to validate
the medicinal uses of these plants. To this effect, if
results from the present study could be extended and
translated in vivo, then it can be safely suggested that
ingestion of crude leaf decoctions of these medicinal
plants might be beneficial in the long term manage-
ment of diabetes. It is believed that these active phyto-
chemicals from the plant extracts could restore the
imbalance between formation of ROS and antioxidants
observed in vivo which has been strongly implicated
to play a major role in multiple chronic diseases includ-
ing diabetes.
Conclusion
In conclusion, crude aqueous and methanol extracts as
well as the organic fractions (mainly ethylacetate and n-
butanol fractions) of AM, FF and OT only were found to
possess potent antioxidant, antiglycation properties and
showed no cytotoxicity which tend to support their use
in the traditional medicines of the Mascarene Islands.
The mechanism of action by which the extracts inhibited
glycation is undoubtedly complex. However, it can be
argued that the anti-glycation capacity was linked to the
antioxidant potentials. Hence, it can be suggested that
these plants might have possible prophylactic andtherapeutic potentials in the management of diabetes
and related complications. Certainly, more studies
related to the structure of these phytochemicals and the
mechanism(s) of action are required in order to under-
stand their anti-glycation and antioxidant effects.
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